欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/0918/002
药品名称Numeta G16E
活性成分
    • Alanine 4.66 g
    • Arginine 4.89 g
    • Aspartic acid 3.5 g
    • Calcium chloride 2.06 g
    • Cysteine 1.1 g
    • Glucose monohydrate 550.0 g
    • Glutamic acid 5.83 g
    • Glycine 2.33 g
    • Histidine 2.21 g
    • Isoleucine 3.9 g
    • leucine 5.83 g
    • Lysine monohydrate 7.2 g
    • Magnesium acetate 1.51 g
    • Methionine 1.4 g
    • OLIVE OIL 0.0 g
    • Ornithine hydrochloride 1.85 g
    • Phenylalanine 2.45 g
    • Potassium acetate 5.05 g
    • Proline 1.75 g
    • Serine 2.33 g
    • Sodium chloride 1.37 g
    • Sodium glycerophosphate 4.43 g
    • SOYBEAN OIL 0.0 g
    • Taurine 0.35 g
    • Threonine 2.16 g
    • Tryptophan 1.17 g
    • Tyrosine 0.45 g
    • Valine 4.43 g
剂型Emulsion for infusion
上市许可持有人Baxter Medical AB Sweden
参考成员国 - 产品名称Sweden (SE)
Numeta G16E
互认成员国 - 产品名称
    • Germany (DE)
      NUMETA Ped G 16% E Emulsion zur Infusion
    • Denmark (DK)
      Numeta Ped G16%E
    • Belgium (BE)
      Numetzah G16%E émulsion pour perfusion
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Numeta G 16 % E Emulsion zur Infusion
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Norway (NO)
    • Czechia (CZ)
      NUMETA Ped G16%E, Emulsion for infusion
    • Finland (FI)
    • Poland (PL)
      NUMETA G16% E
许可日期2010/12/15
最近更新日期2024/10/23
药物ATC编码
    • B05BA10 combinations
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase